Imara to webcast conference call of full year 2021 financial results and business highlights

Boston, march 08, 2022 (globe newswire) -- imara inc. (nasdaq: imra), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare hemoglobin disorders and other serious diseases, today announced that the company will host a conference call and live webcast on tuesday, march 15, at 8:30 a.m. et to discuss its financial results for the year ended december 31, 2021 and review recent business highlights.
ELVN Ratings Summary
ELVN Quant Ranking